Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.

Domínguez F, Cuenca S, Bilińska Z, Toro R, Villard E, Barriales-Villa R, Ochoa JP, Asselbergs F, Sammani A, Franaszczyk M, Akhtar M, Coronado-Albi MJ, Rangel-Sousa D, Rodriguez-Palomares JF, Jiménez-Jáimez J, Garcia-Pinilla JM, Ripoll-Vera T, Mogollón-Jiménez MV, Fontalba-Romero A, Garcia-Medina D, Palomino-Doza J, de Gonzalo-Calvo D, Cicerchia M, Salazar-Mendiguchia J, Salas C, Pankuweit S, Hey TM, Mogensen J, Barton PJ, Charron P, Elliott P, Garcia-Pavia P; European Genetic Cardiomyopathies Initiative Investigators.

J Am Coll Cardiol. 2018 Nov 13;72(20):2471-2481. doi: 10.1016/j.jacc.2018.08.2181.

PMID:
30442290
2.

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Ochoa JP, Sabater-Molina M, García-Pinilla JM, Mogensen J, Restrepo-Córdoba A, Palomino-Doza J, Villacorta E, Martinez-Moreno M, Ramos-Maqueda J, Zorio E, Peña-Peña ML, García-Granja PE, Rodríguez-Palomares JF, Cárdenas-Reyes IJ, de la Torre-Carpente MM, Bautista-Pavés A, Akhtar MM, Cicerchia MN, Bilbao-Quesada R, Mogollón-Jimenez MV, Salazar-Mendiguchía J, Mesa Latorre JM, Arnaez B, Olavarri-Miguel I, Fuentes-Cañamero ME, Lamounier A Jr, Pérez Ruiz JM, Climent-Payá V, Pérez-Sanchez I, Trujillo-Quintero JP, Lopes LR, Repáraz-Andrade A, Marín-Iglesias R, Rodriguez-Vilela A, Sandín-Fuentes M, Garrote JA, Cortel-Fuster A, Lopez-Garrido M, Fontalba-Romero A, Ripoll-Vera T, Llano-Rivas I, Fernandez-Fernandez X, Isidoro-García M, Garcia-Giustiniani D, Barriales-Villa R, Ortiz-Genga M, García-Pavía P, Elliott PM, Gimeno JR, Monserrat L.

J Am Coll Cardiol. 2018 Nov 13;72(20):2457-2467. doi: 10.1016/j.jacc.2018.10.001.

3.

Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia.

Ripoll-Vera T, Alvarez-Rubio J.

Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):26. doi: 10.21542/gcsp.2018.26. Review. No abstract available.

4.

Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention.

González Saldivar H, Vicent Alaminos L, Rodríguez-Pascual C, de la Morena G, Fernández-Golfín C, Amorós C, Baquero Alonso M, Martínez Dolz L, Ariza Solé A, Guzmán-Martínez G, Gómez-Doblas JJ, Arribas Jiménez A, Fuentes ME, Galian Gay L, Ruiz Ortiz M, Avanzas P, Abu-Assi E, Ripoll-Vera T, Díaz-Castro O, Pozo Osinalde E, Bernal E, Martínez-Sellés M.

Rev Esp Cardiol (Engl Ed). 2018 Jul 8. pii: S1885-5857(18)30218-4. doi: 10.1016/j.rec.2018.03.023. [Epub ahead of print] English, Spanish.

PMID:
29997054
5.

Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.

Ripoll-Vera T, Buades J, Cisneros E, Gómez Y, Núñez J, Raya M.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):92-94. doi: 10.1016/j.rec.2017.11.017. Epub 2017 Dec 7. English, Spanish. No abstract available.

PMID:
29223374
6.

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Dominguez F, Climent V, Zorio E, Ripoll-Vera T, Salazar-Mendiguchía J, García-Pinilla JM, Urbano-Moral JA, Fernández-Fernández X, Lopez-Cuenca D, Ajo-Ferrer R, Sanz-Sanchez J, Gomez-Perez Y, López-Garrido MA, Barriales-Villa R, Gimeno JR, Garcia-Pavia P.

Int J Cardiol. 2017 Dec 1;248:232-238. doi: 10.1016/j.ijcard.2017.08.010. Epub 2017 Aug 7.

PMID:
28811092
7.

Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy.

Mirelis JG, Sánchez-González J, Zorio E, Ripoll-Vera T, Salguero-Bodes R, Filgueiras-Rama D, González-López E, Gallego-Delgado M, Fernández-Jiménez R, Soleto MJ, Núñez J, Pizarro G, Sanz J, Fuster V, García-Pavía P, Ibáñez B.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):933-940. doi: 10.1016/j.rec.2017.01.026. Epub 2017 Mar 22. English, Spanish.

PMID:
28341414
8.

Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

Alejandra Restrepo-Cordoba M, Campuzano O, Ripoll-Vera T, Cobo-Marcos M, Mademont-Soler I, Gámez JM, Dominguez F, Gonzalez-Lopez E, Padron-Barthe L, Lara-Pezzi E, Alonso-Pulpon L, Brugada R, Garcia-Pavia P.

J Cardiovasc Transl Res. 2017 Feb;10(1):35-46. doi: 10.1007/s12265-017-9730-8. Epub 2017 Jan 30. Review.

PMID:
28138913
9.

Early diagnosis in patients with transthyretin familial amyloid polyneuropathy: A comparative study.

Raya-Cruz M, Buades-Reines J, Gállego-Lezáun C, Ripoll-Vera T, Usón-Martín M, Cisneros-Barroso E.

Med Clin (Barc). 2017 Jan 20;148(2):63-66. doi: 10.1016/j.medcli.2016.09.044. Epub 2016 Dec 3. English, Spanish.

PMID:
27919414
10.

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.

Buades-Reinés J, Raya-Cruz M, Gallego-Lezaún C, Ripoll-Vera T, Usón-Martín M, Andreu-Serra H, Cisneros-Barroso E.

J Peripher Nerv Syst. 2016 Dec;21(4):352-356. doi: 10.1111/jns.12180.

PMID:
27403623
11.

Comparison of 1-Year Outcome in Patients With Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry).

González-Saldivar H, Rodriguez-Pascual C, de la Morena G, Fernández-Golfín C, Amorós C, Alonso MB, Dolz LM, Solé AA, Guzmán-Martínez G, Gómez-Doblas JJ, Jiménez AA, Fuentes ME, Gay LG, Ortiz MR, Avanzas P, Abu-Assi E, Ripoll-Vera T, Díaz-Castro O, Osinalde EP, Martínez-Sellés M; Influencia del Diagnóstico de Estenosis Aórtica Severa—Influence of the Severe Aortic Stenosis Diagnosis (IDEAS) Investigators.

Am J Cardiol. 2016 Jul 15;118(2):244-50. doi: 10.1016/j.amjcard.2016.04.044. Epub 2016 May 5.

PMID:
27239021
12.

Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms.

Barriales-Villa R, Gimeno-Blanes JR, Zorio-Grima E, Ripoll-Vera T, Evangelista-Masip A, Moya-Mitjans A, Serratosa-Fernández L, Albert-Brotons DC, García-Pinilla JM, García-Pavía P.

Rev Esp Cardiol (Engl Ed). 2016 Mar;69(3):300-9. doi: 10.1016/j.rec.2015.11.029. Epub 2016 Feb 6.

PMID:
26856793
13.

Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.

Ripoll-Vera T, Gámez JM, Govea N, Gómez Y, Núñez J, Socías L, Escandell Á, Rosell J.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):149-58. doi: 10.1016/j.rec.2015.06.025. Epub 2015 Oct 24.

PMID:
26507537
14.

Phenotypic Patterns of Cardiomyopathy Caused by Mutations in the Desmin Gene. A Clinical and Genetic Study in Two Inherited Heart Disease Units.

Ripoll-Vera T, Zorio E, Gámez JM, Molina P, Govea N, Crémer D.

Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):1027-9. doi: 10.1016/j.rec.2015.07.007. Epub 2015 Oct 1. No abstract available.

PMID:
26431784
15.

Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis.

Martínez-Sellés M, Díez-Villanueva P, Sánchez-Sendin D, Carro Hevia A, Gómez Doblas JJ, García de la Villa B, Cornide L, Alonso Tello A, Andión Ogando R, Ripoll Vera T, Arribas Jiménez A, Carrillo P, Rodríguez Pascual C, Casares I Romeva M, Borras X, Vázquez S, López-Palop R; PEGASO Registry Group.

Int J Cardiol. 2015;189:61-6. doi: 10.1016/j.ijcard.2015.04.017. Epub 2015 Apr 4.

PMID:
25885873
16.

[Epidemiological characteristics of out-of-hospital cardiorespiratory arrest recorded by the 061 emergencies system (SAMU) in the Balearic Islands (Spain), 2009-2012].

Socias Crespí L, Ceniceros Rozalén MI, Rubio Roca P, Martínez Cuellar N, García Sánchez A, Ripoll Vera T, Lesmes Serrano A.

Med Intensiva. 2015 May;39(4):199-206. doi: 10.1016/j.medin.2014.04.004. Epub 2014 Dec 12. Spanish.

17.

Comments on the 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy.

Spanish Society of Cardiology Working Group for the 2013 ESC Guidelines on Cardiac Pacing and Cardial Resynchronization Therapy, Fernández Lozano I, Mateas FR, Osca J, Sancho Tello MJ, García Bolao I, Martínez Ferrer J, Fidalgo Andrés ML, Rodríguez García J; Expert Reviewers for the 2013 ESC Guidelines on Cardiac Pacing and Resynchronization Therapy, Leal del Ojo J, Ripoll Vera T, Coma Sanmartín R, Cano Pérez O, Pombo Jimenez M, Medina Palomo C, Pérez Álvarez L, Hernández Madrid A, Perez Castellano N, Mont Girbau L, Mitjans AM, Arribas F, Merino Llorens JL, Pérez Villacastín J, Alzueta Rodriguez J, Carmona Salinas JR; Clinical Practice Guidelines Committee of the Spanish Society of Cardiology, Fernández-Ortiz A, Alonso AM, Anguita M, Cequier Á, Comín J, Diaz-Buschmann I, Fernández Lozano I, Gómez de Diego JJ, Pan M, Worner F.

Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):6-14. doi: 10.1016/j.rec.2013.11.002. No abstract available.

PMID:
24774258
18.

Usefulness of genetic testing for hypertrophic cardiomyopathy in real-world practice.

Cobo-Marcos M, Cuenca S, Gámez Martínez JM, Bornstein B, Ripoll Vera T, Garcia-Pavia P.

Rev Esp Cardiol (Engl Ed). 2013 Sep;66(9):746-7. doi: 10.1016/j.rec.2013.04.003. Epub 2013 Jul 5. No abstract available.

PMID:
24773685
19.

Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention.

Martínez-Sellés M, Gómez Doblas JJ, Carro Hevia A, García de la Villa B, Ferreira-González I, Alonso Tello A, Andión Ogando R, Ripoll Vera T, Arribas Jiménez A, Carrillo P, Rodríguez Pascual C, Casares i Romeva M, Borras X, Cornide L, López-Palop R; PEGASO Registry Group.

J Intern Med. 2014 Jun;275(6):608-20. doi: 10.1111/joim.12174. Epub 2014 Mar 27.

20.

Frequency and outcomes of concomitant use of proton pump inhibitors and clopidogrel after hospital discharge.

Mas-Morey P, Calderón-Hernanz B, Oliver-Noguera A, Ripoll-Vera T, Vilanova-Boltó M.

Therapie. 2013 Mar-Apr;68(2):113-5. doi: 10.2515/therapie/2013013. Epub 2013 Jun 18.

PMID:
23773352

Supplemental Content

Loading ...
Support Center